Closing the gaps: a full scan of the intestinal expression of p-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in male and female rats.
about
Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriersCircadian variations in exsorptive transport: in situ intestinal perfusion data and in vivo relevance.Intestinal ciprofloxacin efflux: the role of breast cancer resistance protein (ABCG2).Mass spectrometry-based targeted proteomics as a tool to elucidate the expression and function of intestinal drug transporters.The Effects of Pregnenolone 16α-Carbonitrile Dosing on Digoxin Pharmacokinetics and Intestinal Absorption in the Rat.ABC transporters in human lymphocytes: expression, activity and role, modulating factors and consequences for antiretroviral therapies.Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response.Gender-dependent differences in uridine 5'-diphospho-glucuronosyltransferase have implications in metabolism and clearance of xenobiotics.Intestinal transporters: enhanced absorption through P-glycoprotein-related drug interactions.Precision-cut intestinal slices: alternative model for drug transport, metabolism, and toxicology research.Alisol F 24 Acetate Enhances Chemosensitivity and Apoptosis of MCF-7/DOX Cells by Inhibiting P-Glycoprotein-Mediated Drug Efflux.Role of drug efflux and uptake transporters in atazanavir intestinal permeability and drug-drug interactions.P-gp activity and inhibition in the different regions of human intestine ex vivo.P-glycoprotein multidrug transporter in inflammatory bowel diseases: More questions than answers.Transport of gemifloxacin, a 4th generation quinolone antibiotic, in the Caco-2 and engineered MDCKII cells, and potential involvement of efflux transporters in the intestinal absorption of the drug.The colon carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is actively secreted in the distal colon of the rat: an integrated view on the role of PhIP transport and metabolism in PhIP-induced colon carcinogenesis.Multidrug resistance proteins restrain the intestinal absorption of trans-resveratrol in rats.Pharmacokinetic modeling to assess factors affecting the oral bioavailability of the lactone and carboxylate forms of the lipophilic camptothecin analogue AR-67 in rats.Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.Determination of intestinal permeability of rigosertib (ON 01910.Na, Estybon): correlation with systemic exposure.Involvement of UDP-Glucuronosyltransferases and Sulfotransferases in the Excretion and Tissue Distribution of Resveratrol in Mice.Impact of a high-cholesterol diet on expression levels of Niemann-Pick C1-like 1 and intestinal transporters in rats and mice.Single- and Multiple-Dose Trials to Determine the Pharmacokinetics, Safety, Tolerability, and Sex Effect of Oral Ginsenoside Compound K in Healthy Chinese Volunteers.The absorption enhancement of norisoboldine in the duodenum of adjuvant-induced arthritis rats involves the impairment of P-glycoprotein.Gender-related differences on P-glycoprotein-mediated drug intestinal transport in rats.Absorption characteristic of paeoniflorin-6'-O-benzene sulfonate (CP-25) in in situ single-pass intestinal perfusion in rats.Hepatobiliary and intestinal elimination of darunavir in an integrated preclinical rat model.In Vitro and In Situ evaluation of pH-dependence of atazanavir intestinal permeability and interactions with acid-reducing agentsProdrugs for colon-restricted delivery: Design, synthesis, and in vivo evaluation of colony stimulating factor 1 receptor (CSF1R) inhibitorsMetabolites and tissue distribution of resveratrol in the pig
P2860
Q26852773-3BC2C799-F2ED-4A64-A166-0B1CE28E8018Q34226780-85CDFFD6-967D-4D7B-9220-1FAD83B5E5E6Q35579522-4ACCFAF4-BC44-43E5-A1FD-8C64D877B978Q37207759-AF526776-65A7-40D0-8747-5D160E2724E3Q37669983-3AF88858-7E50-4640-A767-D190CE585970Q37724178-F8B98343-2047-45CC-B9E8-5EB77E6578A7Q37964754-EF28958B-2143-4A03-BA23-78768BDCEF8BQ38134859-1F7AA486-72B8-43BF-83FC-4DB60A0B5B31Q38202698-0042E9F3-A7B7-438C-AFC5-7DE176B3C466Q38691889-A4BF3658-E2EA-4647-A90D-3F08517E0474Q38795351-AF3595E7-A24E-45C2-9243-B0C0D68DC887Q39229674-CB22D21E-C245-4D93-A124-F6DC8935D81EQ39272976-F8149C9F-B68E-4C7A-9BB6-5B46D74E704FQ42317765-73CBFDC5-A695-47A3-91D9-4AA5FD7EA067Q42513426-ADF65F23-B8B5-49AA-82B5-9428C5508674Q42713432-D1A6D836-A916-476A-B308-1CEAD71E9BB4Q43188243-E4A6F73F-71E4-4F24-9747-9AC38D48E36EQ44076450-7947A217-DB32-4A3C-94F0-07C207EC70D7Q45960885-1335FFB8-7370-4ABB-8C87-453EC0A2D36DQ46329890-A313AA03-B0B4-430D-84A9-92F241799BFEQ46585113-AD095C11-68B9-43DC-8DCD-E40625C2D523Q46767535-AE45FA45-5D40-4FBB-B063-598411AA9622Q49632028-C2DB08EA-681A-43A1-871E-15EDB6A9F316Q51024699-D5D70D80-B2C2-42C6-BA74-ADDD26C2F8C9Q51475986-8079EE3C-7F8D-41DD-94EF-68025E4B79BEQ53803737-E0570914-023D-4DB9-8888-13F68FE3CE7FQ54538651-6A89F027-29F5-4664-9A16-0C04EC417926Q57109564-99C48792-AF5C-4FEA-8101-FEEB1F703F98Q57159795-CC78DE03-840B-43FA-B1BC-F780E1153175Q57759807-8364E792-4A10-458D-9835-DABDFA85804C
P2860
Closing the gaps: a full scan of the intestinal expression of p-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in male and female rats.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Closing the gaps: a full scan ...... ein 2 in male and female rats.
@en
type
label
Closing the gaps: a full scan ...... ein 2 in male and female rats.
@en
prefLabel
Closing the gaps: a full scan ...... ein 2 in male and female rats.
@en
P2093
P356
P1476
Closing the gaps: a full scan ...... ein 2 in male and female rats.
@en
P2093
Andreas Reichel
Caroline MacLean
Gert Fricker
Ulla Moenning
P304
P356
10.1124/DMD.108.020859
P577
2008-03-31T00:00:00Z